Search - tctmd.com

Displaying 281 - 300 of 329

Sort: Relevancy | Date

Presentation TCT 2013

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Presenter: Reda Ibrahim

October 31, 2013

Presentation TCT 2013

DES Implantation in a Patient with Atrial Fibrillation

Presenter: Roxana Mehran

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Presenter: E. Magnus Ohman

October 31, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News TCT 2013

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

October 30, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

The Need for Screening for Atrial Fibrillation

Presenter: David Albert

October 29, 2013

Presentation TCT 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presenter: Taya Glotzer

October 29, 2013

Presentation TCT 2013

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

Presenter: Mintu Turakhia

October 29, 2013

Presentation TCT 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presenter: Vivek Reddy

October 29, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Presenter: Vivek Reddy

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

Presentation TCT 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presenter: C. Michael Gibson

October 29, 2013

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

Advertisement

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

DES Implantation in a Patient with Atrial Fibrillation

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

TCT Leadership Outlines the State of Intervention

Innovation in Intervention: Perspectives from Industry

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

The Need for Screening for Atrial Fibrillation

Silent Atrial Fibrillation: An Under-Appreciated Threat

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Preliminary Data Show Potential of Renal Denervation in Several Settings

Experts Discuss Efficacy, Safety of Watchman Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content